首页 | 本学科首页   官方微博 | 高级检索  
检索        

3D-CRT放疗同步联合TP方案化疗治疗晚期食管癌
引用本文:杨林,殷洁,何涛.3D-CRT放疗同步联合TP方案化疗治疗晚期食管癌[J].安徽卫生职业技术学院学报,2013,12(2):39-40.
作者姓名:杨林  殷洁  何涛
作者单位:杨林 (池州市第二人民医院肿瘤科,安徽,247100);殷洁 (池州市第二人民医院肿瘤科,安徽,247100);何涛 (池州市第二人民医院肿瘤科,安徽,247100);
摘    要:目的:观察3D-CRT放疗同步联合TP方案化疗治疗食管癌的疗效。方法:对40例食管癌患者采取三维适行放疗同步TPF方案肿瘤照射剂量为56-62gy,化疗采用紫杉醇联合顺铂方案。结果:完全缓解(CR)+部分缓解(PR)为32例,达到80%,1-3年生存率为68%、40%、21%。结论:3D-CRT放疗同步联合TP方案化疗治疗晚期食管癌疗效明显,可以耐受,对缓解症状、提高生存质量起到了积极作用。

关 键 词:食管癌  三维适形放射治疗  同步化疗

The clinical observation of esophageal carcinoma with three dimensional conformal radiation therapy with chemotherapy
The Second People's Hospital of Chizhou,Chizhou,Anhui YANG Lin,YIN Jie,HE Tao.The clinical observation of esophageal carcinoma with three dimensional conformal radiation therapy with chemotherapy[J].Journal of Anhui Heaith Vocational & Technical College,2013,12(2):39-40.
Authors:The Second People's Hospital of Chizhou  Chizhou  Anhui YANG Lin  YIN Jie  HE Tao
Institution:The Second People's Hospital of Chizhou, Chizhou 247100, Anhui YANG Lin,YIN Jie,HE Tao
Abstract:Objective:To evaluate the clinical therapeutic efficacy and toxicity of three-dimensional conformal radiotherapy with concurrent chemotherapy with paclitaxel combined cisplatin intreatment esophageal carcinoma. Methods:3D-CRT was used for RT,the total tumor dose was 55-62gy, and PTX+ DDP was used for CT. Results:the efficacy was 1 month after the end oftreatmen:CR+ PR32cases The overall etticaey ratewas 80%. The 1,2,3-years survival rates were68%,40%,21%. Conclusion:Three-dimensional conformal radiotherapy with concurrent chemotherapy has good efficacy in treatment of esophageal carcinoma,and the toxic reactions are tolerable.and can relieve symptoms and improve survival quality.
Keywords:esophageal carcinoma  Three-dimensional conformal radiotherapy  Concurrent chemotherapy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号